In 2019, the top 10 therapeutic classes accounted for 76.8% of all scripts and 79.6% of all costs. An understanding of the most-utilized and highest-ranked classes of medications by cost can drive intervention opportunities and benchmark targeted efforts for pharmacy program management. Year-over-year trend changes can also guide decision-making and identify drug class utilization and cost outliers that may warrant further evaluation for appropriateness and safety.
Watch the video blog here.
Q2 CASUALTY REPORT 2024
Utilization Review (UR) plays a crucial role in the workers' compensation system, ensuring that medical treatments provided to injured employees ar
New report reveals current trends for P&C industry SAN DIEGO, Calif.—Medical costs nationally have risen 11% in workers
Each quarter, Enlyte publishes its medical price index (MPI), which analyzes Enlyte’s medical bill review professional services charge data for tre
As reported by the Bureau of Labor and Statistics (BLS) for April 2024, the
